Repligen | Pasivo Circulante



Current Liabilities Cambio Fecha
Agilent USD 1.87B 26M 2025-01
Align Technology USD 2.04B 25.59M 2024-12
Bio Techne USD 161.26M 19.13M 2024-12
BioMarin Pharmaceutical USD 606.99M 108.67M 2024-12
Bristol-Myers Squibb USD 23.77B 1.14B 2024-12
Bruker USD 1.28B 37.5M 2024-12
Charles River Laboratories USD 994.1M 18.12M 2024-12
Danaher USD 6.8B 541M 2024-12
Dentsply International USD 1.59B 47M 2024-12
Exact Sciences USD 732.19M 8.52M 2024-12
General Electric USD 34.39B 299M 2024-12
Henry Schein USD 2.8B 126M 2024-12
Illumina USD 1.55B 572M 2024-12
IQVIA Holdings USD 6.96B 35M 2024-12
Mettler Toledo International USD 1.17B 16.77M 2024-12
Myriad Genetics USD 164.1M 9.8M 2024-12
Patterson Companies USD 1.31B 39.02M 2025-01
Pfizer USD 43B 216M 2024-12
Repligen USD 108.37M 65.94M 2024-09
Revvity USD 653.1M 34.84M 2024-12
Standard Biotools USD 65.89M 54.72M 2024-12
Thermo Fisher Scientific USD 13.33B 1.27B 2024-12
Waters USD 789.76M 26.28M 2024-12
West Pharmaceutical Services USD 550.4M 33.9M 2024-12



Repligen Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2025.